MonaLisa Touch - A Breakthrough in the Non-Invasive Treatment of Vaginal Atrophy
Inspired By the Best in Anti-Ageing Laser Therapy
The inspiration for one of the most significant advancements in vaginal health has come from the laser that changed the way laser wrinkle reduction and skin texture improvement was performed.
The Smartxide ‘DOT Therapy’ laser has been used for many years for effective anti-ageing treatments on delicate areas such as the face, eyelids and neck. The advanced technology that allowed laser pulses to be tailored to each patient’s skin type and body area has led to the development of this innovation in treatment of vaginal atrophy.
The MonaLisa Touch treatment adds a new dimension to the treatment of this important health issue for women. It provides the ability to stimulate the natural regeneration of the vaginal tissue and counteract the physical and emotionally draining effects of vaginal atrophy.
A Revolutionary Treatment Creating lasting improvements for Women affected by the symptoms of vaginal atrophy.
- Vaginal itchiness & Burning
- Dryness & loss of lubrication
- Incontinence & urinary urgency;
- Vaginal & vulval pain
- Painful sexual intercourse
- Recurrent thrush and UTI's
- Vaginal laxity
Recent peer-reviewed research published by the International Menopause Society has demonstrated that a series of three, five-minute treatments are achieving significant clinical improvements. MonaLisa Touch was introduced into Australia in January 2013 and more than 2000 treatments have now been performed. The treatment results have exceeded the doctor’s expectations and for many patients the results of the MonaLisa Touch procedure have been life-changing.
MonaLisa Touch is a low-risk procedure that provides longer-lasting improvements than HRT. It can be used in conjunction with HRT, as an alternative treatment for patients who are not suitable for HRT or for those patients who have found HRT to be ineffective. Patients can return to their normal daily activities immediately with the only post-treatment instruction being no sexual activity for five days.
Patients who can benefit from this treatment are –
- Women with breast cancer who have atrophic vaginal symptoms
- Women who have had radiotherapy for bowel or uterine/cervical cancer with narrowing and atrophic vaginal symptoms
- Women with vaginal atrophy who haven’t responded to topical HRT
- Women with painful perineal scarring post-nataly
- Women with severe atrophic vaginitis due to breast feeding and contraception
- Women on continuous OCP with vaginal atrophy not responding to medical management
- Women with lichen sclerosis but no VIN
- Women with recurrent thrush having had all possible fungal and medical treatments.
About The MonaLisa Touch Treatment
MonaLisa Touch works by stimulating the body’s own regenerative processes to create more hydrated and healthy cells and to improve the vascularity of the vaginal mucosa. This has a direct effect on the integrity and elasticity of the vaginal wall and increases the acidity of the vaginal environment to more normal levels. In general terms MonaLisa Touch improves the function and health of the vagina.
The treatment activates fibroblasts of the vaginal mucosa which promotes collagen synthesis. The permeability of the tissues and the transfer of water and nutrients from the capillaries are also improved, allowing normal water content of the vaginal mucosa which restore the vaginal wall strength and blood supply. In as little as 30 days after the treatment the regeneration of new tissue in the vaginal walls builds a naturally stronger structure and the protective mucosa recovers volume, hydration and elasticity. The MonaLisa Touch treatment can stimulate the production of vaginal secretions and assist with the problems related to a dry vagina.
Contributing Factors to Vaginal Atrophy Symptoms
The reduction of oestrogen production in the ovaries after menopause is the most recognised cause of vaginal atrophy. This results in a reduction of collagen in the vaginal mucosa and thinning of the epithelium, which makes the vagina more susceptible to trauma during intercourse. A concomitant reduction in blood flow leads to a decrease in vaginal secretions often leading to a dry vagina. This in turn decreases the lactobacilli bacteria of the vagina which results in an increased pH level, facilitating the growth of pathogens such as yeasts and bacteria. This can result in an unpleasant vaginal odour and recurrent thrush.
Effective treatment of vaginal atrophy should start before the occurrence of vaginal changes and it is best to do so before the onset of vaginal atrophy. MonaLisa Touch can significantly improve the structure of the vaginal mucosa, resulting in vaginal atrophy-related problems being remedied.
The challenges of vaginal atrophy
From the time menopause approaches a loss of estrogenic hormones can cause changes in the structure and function of the vagina.
The walls of the vagina lose collagen, become thinner and the natural elasticity and blood supply is reduced. The protective mucosa of the vagina can lose hydration and thickness, causing a loss of lubrication and changes in the natural balance of the internal environment. These symptoms can have a negative effect on your general well-being and, in many cases place stress on your intimate relationships.
Existing Treatment Options
Currently the most-common treatment of vaginal atrophy requires an ongoing application of hormone replacement creams directly into the vagina. For a variety of reasons some women are not able to use these creams, become uncomfortable with this process or are irregular with the application and eventually discontinue use.
Without an effective solution these women are forced to alter their lifestyle to cope with the symptoms.
Stimulating Natural Regeneration with MonaLisa Touch
A light-based solution to help you feel like you again…
In the past, laser procedures for gynaecology were largely reserved for invasive surgical procedures. The MonaLisa Touch treatment has transformed the application of this technology to create a procedure that is minimally-invasive and available to almost all women.
MonaLisa Touch is the first solution designed to naturally counteract the effects of hypotrophy of the vaginal mucosa. By stimulating the regeneration of new vaginal tissue MonaLisa Touch restores your body’s natural balance and function.
You can begin to feel like you again….and rediscover the confidence to live the lifestyle you choose.
How MonaLisa Touch works to restore function and balance
The MonaLisa Touch treatment is a fast and effective treatment that uses hundreds of tiny pillars of laser energy to stimulate the natural regeneration of the vaginal tissue.
In as little as 30 days after treatment the regeneration of new tissue in the vaginal walls builds a naturally stronger structure and the protective mucosa recovers volume, hydration and elasticity – all without the side effects of traditional treatments.
Risks and side effects
- Minor vaginal or pelvic discomfort
- Watery vaginal discharge for few days
- Vaginal spotting for a day or two
The MonaLisa Touch treatment takes around ten minutes. There is no downtime required after the treatment and you can return to your normal activities immediately. But avoid intercourse or having a bath for five days.
Are the Results Permanent?
All the changes obtained with the MonaLisa Touch treatment are long lasting. As the natural ageing process continues the treatment can be repeated as required.
How Many Treatments Are Required?
Most patients fell an improvement after the first treatment with the full benefits of the MonaLisa Touch treatment achieved in three to four treatments. This can be decided in consultation with your Doctor.
Key Benefits of The MonaLisa Touch Treatment
MonaLisa Touch treatments offer an effective and convenient solution to counteract the effects of vaginal atrophy.
Key benefits include:
- Painless treatment
- Minor side effect
- Suitable for almost all women
- Achieves long-lasting improvements
- Patients can return to normal activities immediately with no downtime
- Able to be used by certain patient groups who are unsuitable for hormone replacement therapy, eg. Breast cancer patients
- Most patients experience noticeable improvements after just one treatment.